Tag: Renal Cell Carcinoma

EMUC17: Using biomarkers in decision-making for RCC treatment

Renal cell carcinomas are among the most lethal in urological malignancies prompting doctors to search for tools such as biomarkers and other molecular techniques to distinguish aggressive diseases. With new research outcomes, physicians are hopeful that diagnosis and therapy...

EMUC16: Kidney cancer — from diagnosis to progression

Improving diagnosis and mapping out optimal treatment strategies for kidney cancer patients topped the second-day agenda of the 8th European Meeting on Urological Cancers (EMUC16) in Milan, Italy. The fourth plenary session focused on the challenges in kidney cancer...

EMUC15: Challenges in kidney cancers

There are notable gains in the diagnosis of uncommon renal tumours but patients need to be enrolled in clinical studies or referred to high-volume centres for researchers to reach more meaningful outcomes.   “Non-clear cell renal cell carcinoma (nccRCC)...

EMUC15: Systemic treatment for metastatic kidney cancer

New drug combinations, side-effects of systemic therapy and prospects in the management of renal cell carcinoma were taken up in the second plenary session of the 7th European Multidisciplinary Meeting on Urological Cancers  (EMUC15) with experts weighing in the...
12th CEM: management issues in renal cell cancer

12th CEM: management issues in renal cell cancer

Management issues in renal cell cancer particularly the role of biopsy, active surveillance, partial nephrectomy and palliative surgery were taken up in the second-day plenary session of the 12th Central European Meeting (CEM) held in Dresden, Germany. Speakers Attila...
Patient selection: crucial in RCC treatment

Patient selection: crucial in RCC treatment

With the entry of so-called targeted therapy (TT), patient selection and individualised treatment strategies will become more crucial in the coming years in treating kidney cancer patients who have either localised or metastatic disease, according to experts who examined...
8th ESOU Meeting: renal cancer session, key messages

8th ESOU Meeting: renal cancer session, key messages

The 8th EAU Section of Oncological Urology (ESOU) Meeting held over the weekend in London, United Kingdom, re-examined medical and surgical issues in renal cell cancer with topics covering targeted therapies, focal therapy, laparoscopic nephrectomy, small renal tumours, surgery...